JP2022513846A5 - - Google Patents

Info

Publication number
JP2022513846A5
JP2022513846A5 JP2021533779A JP2021533779A JP2022513846A5 JP 2022513846 A5 JP2022513846 A5 JP 2022513846A5 JP 2021533779 A JP2021533779 A JP 2021533779A JP 2021533779 A JP2021533779 A JP 2021533779A JP 2022513846 A5 JP2022513846 A5 JP 2022513846A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
tautomer
stereoisomer
solvate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021533779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513846A (ja
JP7642540B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/066201 external-priority patent/WO2020123925A1/en
Publication of JP2022513846A publication Critical patent/JP2022513846A/ja
Publication of JP2022513846A5 publication Critical patent/JP2022513846A5/ja
Application granted granted Critical
Publication of JP7642540B2 publication Critical patent/JP7642540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021533779A 2018-12-14 2019-12-13 C-jun-n末キナーゼのピラゾロピリジンインヒビターおよびそれらの使用 Active JP7642540B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862780066P 2018-12-14 2018-12-14
US62/780,066 2018-12-14
PCT/US2019/066201 WO2020123925A1 (en) 2018-12-14 2019-12-13 Pyrazolopyridine inhibitors of c-jun-n-terminal kinases and uses thereof

Publications (3)

Publication Number Publication Date
JP2022513846A JP2022513846A (ja) 2022-02-09
JP2022513846A5 true JP2022513846A5 (https=) 2022-12-21
JP7642540B2 JP7642540B2 (ja) 2025-03-10

Family

ID=71077020

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533779A Active JP7642540B2 (ja) 2018-12-14 2019-12-13 C-jun-n末キナーゼのピラゾロピリジンインヒビターおよびそれらの使用

Country Status (7)

Country Link
US (1) US20220073512A1 (https=)
EP (1) EP3893879A4 (https=)
JP (1) JP7642540B2 (https=)
CN (1) CN113164477A (https=)
AU (1) AU2019395255B2 (https=)
CA (1) CA3115126A1 (https=)
WO (1) WO2020123925A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011090738A2 (en) 2009-12-29 2011-07-28 Dana-Farber Cancer Institute, Inc. Type ii raf kinase inhibitors
JP6854762B2 (ja) 2014-12-23 2021-04-07 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド サイクリン依存性キナーゼ7(cdk7)の阻害剤
USRE50776E1 (en) 2015-03-27 2026-02-03 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinases
AU2017363307B2 (en) * 2016-11-22 2021-07-29 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 12 (CDK12) and uses thereof
US12281126B2 (en) 2018-12-28 2025-04-22 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 and uses thereof
CA3147422A1 (en) * 2019-07-17 2021-01-21 Kinnate Biopharma Inc. Inhibitors of cyclin-dependent kinases
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
CN120661695B (zh) * 2025-06-20 2026-03-20 山东大学齐鲁第二医院 联合上调snrk基因与gsk3b基因表达水平在制备抗非小细胞肺癌药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007123892A2 (en) 2006-04-17 2007-11-01 Arqule Inc. Raf inhibitors and their uses
WO2010144416A1 (en) 2009-06-08 2010-12-16 Gaeta Federico C A SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS HAVING MULTI-TARGET ACTIVITY
BR112013011520A2 (pt) * 2010-11-19 2019-09-24 Hoffmann La Roche pirazolo piridinas e pirazolo piridinas e seu uso como inibidores de tyk2
US9382239B2 (en) 2011-11-17 2016-07-05 Dana-Farber Cancer Institute, Inc. Inhibitors of c-Jun-N-terminal kinase (JNK)
EP2909194A1 (en) 2012-10-18 2015-08-26 Dana-Farber Cancer Institute, Inc. Inhibitors of cyclin-dependent kinase 7 (cdk7)
TWI621618B (zh) * 2013-03-13 2018-04-21 比利時商健生藥品公司 經取代2-氮雜雙環類及其作為食慾素受體調控劑之用途
WO2015058126A1 (en) 2013-10-18 2015-04-23 Syros Pharmaceuticals, Inc. Heteroaromatic compounds useful for the treatment of prolferative diseases
EP3057956B1 (en) * 2013-10-18 2021-05-05 Dana-Farber Cancer Institute, Inc. Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)

Similar Documents

Publication Publication Date Title
JP2022513846A5 (https=)
KR102093608B1 (ko) 이미다조피리딘 화합물
JP2023508982A5 (https=)
JP2023530231A5 (https=)
DK3009426T3 (en) 4-ALKYNYL-IMIDAZOLE DERIVATIVE AND MEDICINE COMPREHENSIVE AS AN ACTIVE INGREDIENT
JP2018515434A5 (https=)
BRPI0607756A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para inibição de dna girase bacteriana e/ou topoisomerase iv em um animal de sangue quente, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para preparar compostos ou sais farmaceuticamente aceitáveis dos mesmos
CN111032651A (zh) 杂环化合物
AU2019220662B2 (en) P300/CBP HAT inhibitors
NZ259114A (en) Pyrazolopyrimidines and pharmaceutical compositions thereof
JP2018522867A5 (https=)
JP2015503621A5 (https=)
JP2006518341A (ja) ヒストンデアセチラーゼ(hdac)阻害剤としてのヒドロキサム酸誘導体
JP2018522866A5 (https=)
TR201807090T4 (tr) Glioksamid sübstitüeli pirrolamid deriveleri ve bunun hepatitin tedavisine yönelik ilaçlar olarak kullanımı.
JP2012522766A5 (https=)
BR112016003247B1 (pt) Composto substituído por quinolina, composição farmacêutica compreendendo o referido composto e seu uso
JP2018529690A5 (https=)
CA3029175A1 (en) Novel pyrazole derivatives as alk5 inhibitors and uses thereof
JP2023542845A (ja) Rnaヘリカーゼdhx33を阻害する多環式化合物及びその応用
AU2013302473A1 (en) Pyrrolopyrazoles as N-type calcium channel blockers
KR20100046064A (ko) 인다졸 아크릴산 아미드 화합물
TW200413369A (en) New compounds
CN112424198A (zh) 噻二嗪衍生物
CA2600175A1 (en) Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors